☰

Claudia A. Benavente, Ph.D. - Publications

Affiliations: 
2002 Universidad de Chile, Santiago, Región Metropolitana, Chile 
 2001-2003 Biologia Celular INTA 
 2003-2007 Cancer Biology University of Arizona, Tucson, AZ 
 2009-2014 Developmental Neurobiology St. Jude Children's Research Hospital, San Francisco, CA, United States 
 2014- Pharmaceutical Sciences University of California, Irvine, Irvine, CA 
Area:
Cell Biology, Molecular Biology, Cancer Biology
Tree Info Grants Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wu SC, Kim A, Gu Y, Martinez DI, Zocchi L, Chen CC, Lopez J, Salcido K, Singh S, Wu J, Nael A, Benavente CA. UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression. Oncogenesis. 11: 51. PMID 36068209 DOI: 10.1038/s41389-022-00430-6  0.641
2020 Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA. Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Cancers. 12. PMID 33003565 DOI: 10.3390/cancers12102807  0.305
2020 Wang S, Drummond ML, Guerrero-Juarez CF, Tarapore E, MacLean AL, Stabell AR, Wu SC, Gutierrez G, That BT, Benavente CA, Nie Q, Atwood SX. Single cell transcriptomics of human epidermis identifies basal stem cell transition states. Nature Communications. 11: 4239. PMID 32843640 DOI: 10.1038/S41467-020-18075-7  0.589
2020 Zocchi L, Wu SC, Benavente CA. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 7: 23-25. PMID 32426419 DOI: 10.18632/oncoscience.502  0.527
2020 Zocchi L, Mehta A, Wu SC, Wu J, Gu Y, Wang J, Suh S, Spitale RC, Benavente CA. Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression. Oncogenesis. 9: 25. PMID 32071286 DOI: 10.1038/s41389-020-0210-7  0.643
2018 Wu SC, Benavente CA. Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis. Oncotarget. 9: 32580-32592. PMID 30220967 DOI: 10.18632/oncotarget.25953  0.64
2018 Zocchi L, Wu SC, Wu J, Hayama KL, Benavente CA. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Oncotarget. 9: 23505-23518. PMID 29805751 DOI: 10.18632/oncotarget.25239  0.612
2015 Aldiri I, Ajioka I, Xu B, Zhang J, Chen X, Benavente C, Finkelstein D, Johnson D, Akiyama J, Pennacchio LA, Dyer MA. Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development (Cambridge, England). 142: 4092-106. PMID 26628093 DOI: 10.1242/Dev.124800  0.565
2015 Benavente CA, Dyer MA. Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma. Methods in Molecular Biology (Clifton, N.J.). 1267: 307-17. PMID 25636476 DOI: 10.1007/978-1-4939-2297-0_15  0.527
2015 Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annual Review of Pathology. 10: 547-62. PMID 25621664 DOI: 10.1146/annurev-pathol-012414-040259  0.523
2014 Stewart E, Goshorn R, Bradley C, Griffiths LM, Benavente C, Twarog NR, Miller GM, Caufield W, Freeman BB, Bahrami A, Pappo A, Wu J, Loh A, Karlström Å, Calabrese C, et al. Targeting the DNA repair pathway in Ewing sarcoma. Cell Reports. 9: 829-41. PMID 25437539 DOI: 10.1016/J.Celrep.2014.09.028  0.515
2014 Benavente CA, Finkelstein D, Johnson DA, Marine JC, Ashery-Padan R, Dyer MA. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget. 5: 9594-608. PMID 25338120 DOI: 10.18632/Oncotarget.2468  0.566
2013 Benavente CA, McEvoy JD, Finkelstein D, Wei L, Kang G, Wang YD, Neale G, Ragsdale S, Valentine V, Bahrami A, Temirov J, Pounds S, Zhang J, Dyer MA. Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget. 4: 844-59. PMID 23765217 DOI: 10.18632/Oncotarget.1051  0.57
2012 Benavente CA, Schnell SA, Jacobson EL. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. Plos One. 7: e42276. PMID 22860104 DOI: 10.1371/Journal.Pone.0042276  0.668
2012 Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 481: 329-34. PMID 22237022 DOI: 10.1038/Nature10733  0.549
2011 Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. Plos One. 6: e20487. PMID 21655214 DOI: 10.1371/Journal.Pone.0020487  0.631
2009 Benavente CA, Jacobson MK, Jacobson EL. NAD in skin: therapeutic approaches for niacin. Current Pharmaceutical Design. 15: 29-38. PMID 19149600 DOI: 10.2174/138161209787185760  0.683
2008 Benavente CA, Jacobson EL. Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free Radical Biology & Medicine. 44: 527-37. PMID 17997992 DOI: 10.1016/J.Freeradbiomed.2007.10.006  0.663
Show low-probability matches.